Drug Trial Radar · NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Last checked: Nov 20, 2026Latest source record: Nov 3, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
303
Planned (sponsor's estimate)
Start
Sep 20, 2017
Primary completion
Nov 1, 2027
Study completion Apr 1, 2028
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- May 12, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This phase III trial studies the side effects of inotuzumab ozogamicin and how well it works when given with frontline chemotherapy in treating patients with newly diagnosed B acute lymphoblastic leukemia. Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemotherapy drug called ozogamicin. Inotuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as CD22 receptors, and delivers ozogamicin to kill them. Chemotherapy drugs, such as \[intervention\], work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving inotuzumab ozogamicin with chemotherapy may work better in treating young adults with B acute lymphoblastic leukemia.
Conditions
- B Acute Lymphoblastic Leukemia
Interventions
AllopurinolDrug
Given PO
CytarabineDrug
Given IT, IV, SC
Daunorubicin HydrochlorideDrug
Given IV
Vincristine SulfateDrug
Given IV
DexamethasoneDrug
Given PO or IV
Pegylated L-AsparaginaseDrug
Given IV
MethotrexateDrug
Given IT, IV, PO
Bone Marrow Aspiration and BiopsyProcedure
Undergo bone marrow aspiration and biopsy
CyclophosphamideDrug
Given IV
MercaptopurineDrug
Given PO
RituximabBiological
Given IV
DoxorubicinDrug
Given IV
ThioguanineDrug
Given PO
Inotuzumab OzogamicinBiological
Given IV
Laboratory Biomarker AnalysisOther
Correlative studies
Primary outcomes
What the sponsor says the trial is designed to measure.
- Event-free survival (EFS)Time frame: Time from induction response to the time of progressive-disease, secondary malignancy, or death, assessed up to 3 years
Locations
460 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham Cancer Center
Birmingham, Alabama · Active not recruiting
Anchorage Associates in Radiation Medicine
Anchorage, Alaska · Suspended
Anchorage Radiation Therapy Center
Anchorage, Alaska · Suspended
Alaska Breast Care and Surgery LLC
Anchorage, Alaska · Suspended
Alaska Oncology and Hematology LLC
Anchorage, Alaska · Suspended
Alaska Women's Cancer Care
Anchorage, Alaska · Suspended
Anchorage Oncology Centre
Anchorage, Alaska · Suspended
Katmai Oncology Group
Anchorage, Alaska · Suspended
Providence Alaska Medical Center
Anchorage, Alaska · Suspended
Fairbanks Memorial Hospital
Fairbanks, Alaska · Suspended
Kingman Regional Medical Center
Kingman, Arizona · Suspended
Mayo Clinic Hospital in Arizona
Phoenix, Arizona · Suspended
Mayo Clinic in Arizona
Scottsdale, Arizona · Withdrawn
Mercy Hospital Fort Smith
Fort Smith, Arkansas · Suspended
Kaiser Permanente-Deer Valley Medical Center
Antioch, California · Recruiting
PCR Oncology
Arroyo Grande, California · Suspended
Providence Saint Joseph Medical Center/Disney Family Cancer Center
Burbank, California · Suspended
Community Cancer Institute
Clovis, California · Recruiting
University Oncology Associates
Clovis, California · Suspended
UC Irvine Health Cancer Center-Newport
Costa Mesa, California · Recruiting
Kaiser Permanente Dublin
Dublin, California · Recruiting
Kaiser Permanente-Fremont
Fremont, California · Recruiting
Fresno Cancer Center
Fresno, California · Suspended
Kaiser Permanente Fresno Orchard Plaza
Fresno, California · Recruiting
Kaiser Permanente-Fresno
Fresno, California · Recruiting
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care
Irvine, California · Recruiting
Kaiser Permanente- Modesto MOB II
Modesto, California · Recruiting
Kaiser Permanente-Modesto
Modesto, California · Recruiting
Kaiser Permanente Oakland-Broadway
Oakland, California · Suspended
Kaiser Permanente-Oakland
Oakland, California · Recruiting
UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California · Recruiting
Stanford Cancer Institute Palo Alto
Palo Alto, California · Recruiting
Kaiser Permanente-Rancho Cordova Cancer Center
Rancho Cordova, California · Suspended
Kaiser Permanente- Marshall Medical Offices
Redwood City, California · Suspended
Kaiser Permanente-Redwood City
Redwood City, California · Suspended
Kaiser Permanente-Richmond
Richmond, California · Recruiting
Rohnert Park Cancer Center
Rohnert Park, California · Suspended
Kaiser Permanente-Roseville
Roseville, California · Recruiting
The Permanente Medical Group-Roseville Radiation Oncology
Roseville, California · Suspended
Kaiser Permanente Downtown Commons
Sacramento, California · Recruiting
Showing 40 of 460 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.